BHMP
MNTA

Bardin Hill Management Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bardin Hill Management Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-239,739
Closed -$12.6M – 57
2020
Q3 		$12.6M Buy
+239,739
New +$9.92M 3.34% 12

Bardin Hill Management Partners's MNTA Position: Q4 2020 in Review

Bardin Hill Management Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 239,739 shares — an estimated $12.6M sold.

Bardin Hill Management Partners first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $12.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Bardin Hill Management Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bardin Hill Management Partners sold 239,739 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $12.6M.
  • Bardin Hill Management Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Bardin Hill Management Partners's Momenta Pharmaceuticals, Inc. position peaked at $12.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Bardin Hill Management Partners's 13F filing for Q4 2020, filed 16 Feb 2021.